|
LM_ID
|
Common Name
|
Systematic Name
|
Species Shorthand
|
Formula
|
Mass
|
|
LMFA02020205
|
(+)-9,10-dihydrojasmonic acid
|
[(1S,2S)-3-oxo-2-pentylcyclopentyl]acetic acid
|
FA 12:2;O
|
C12H20O3
|
212.141245
|
|
LMFA02020205
|
(+)-9,10-dihydrojasmonic acid
|
[(1S,2S)-3-oxo-2-pentylcyclopentyl]acetic acid
|
FA 12:2;O
|
C12H20O3
|
212.141245
|
|
LMFA01170133
|
(Z)-5-oxohex-2-enedioic acid
|
5-oxo-2Z-hexenedioic acid
|
FA 6:3;O3
|
C6H6O5
|
158.021525
|
|
LMFA01170133
|
(Z)-5-oxohex-2-enedioic acid
|
5-oxo-2Z-hexenedioic acid
|
FA 6:3;O3
|
C6H6O5
|
158.021525
|
|
LMFA01170133
|
(Z)-5-oxohex-2-enedioic acid
|
5-oxo-2Z-hexenedioic acid
|
FA 6:3;O3
|
C6H6O5
|
158.021525
|
|
LMFA01020076
|
Isocaproic acid
|
4-methyl-pentanoic acid
|
FA 6:0
|
C6H12O2
|
116.083730
|
|
LMFA07070010
|
(11Z)-eicoseneoylcarnitine
|
3-[(11Z)-icos-11-enoyloxy]-4-(trimethylazaniumyl)butanoate
|
CAR 20:1
|
C27H51NO4
|
453.381810
|
|
LMFA07070010
|
(11Z)-eicoseneoylcarnitine
|
3-[(11Z)-icos-11-enoyloxy]-4-(trimethylazaniumyl)butanoate
|
CAR 20:1
|
C27H51NO4
|
453.381810
|
|
LMFA07010710
|
1-Ethenylhexyl butanoate
|
oct-1-en-3-yl butanoate
|
WE 12:1
|
C12H22O2
|
198.161980
|
|
LMFA07010710
|
1-Ethenylhexyl butanoate
|
oct-1-en-3-yl butanoate
|
WE 12:1
|
C12H22O2
|
198.161980
|
|
LMFA07010780
|
Allyl undecylenate
|
prop-2-en-1-yl undec-10-enoate
|
WE 14:2
|
C14H24O2
|
224.177630
|
|
LMFA07010780
|
Allyl undecylenate
|
prop-2-en-1-yl undec-10-enoate
|
WE 14:2
|
C14H24O2
|
224.177630
|
|
LMFA07010949
|
Methyl 3-mercaptobutanoate
|
methyl 3-sulfanylbutanoate
|
|
C5H10O2S
|
134.040151
|
|
LMFA07010949
|
Methyl 3-mercaptobutanoate
|
methyl 3-sulfanylbutanoate
|
|
C5H10O2S
|
134.040151
|
|
LMFA07010767
|
5-Octenyl propanoate
|
(5Z)-oct-5-en-1-yl propanoate
|
WE 11:1
|
C11H20O2
|
184.146330
|
|
LMFA07010767
|
5-Octenyl propanoate
|
(5Z)-oct-5-en-1-yl propanoate
|
WE 11:1
|
C11H20O2
|
184.146330
|
|
LMFA07070022
|
(7Z,10Z,13Z,16Z)-docosatetraenoylcarnitine
|
3-[(7Z,10Z,13Z,16Z)-docosa-7,10,13,16-tetraenoyloxy]-4-(trimethylazaniumyl)butanoate
|
CAR 22:4
|
C29H49NO4
|
475.366160
|
|
LMFA07070022
|
(7Z,10Z,13Z,16Z)-docosatetraenoylcarnitine
|
3-[(7Z,10Z,13Z,16Z)-docosa-7,10,13,16-tetraenoyloxy]-4-(trimethylazaniumyl)butanoate
|
CAR 22:4
|
C29H49NO4
|
475.366160
|
|
LMFA08020216
|
N-(9,12-octadecadienoyl)-glutamine
|
N-(9Z,12Z-octadecadienoyl)-glutamine
|
NAGln 18:2
|
C23H40N2O4
|
408.298808
|
|
LMFA08020216
|
N-(9,12-octadecadienoyl)-glutamine
|
N-(9Z,12Z-octadecadienoyl)-glutamine
|
NAGln 18:2
|
C23H40N2O4
|
408.298808
|
|
LMFA08020216
|
N-(9,12-octadecadienoyl)-glutamine
|
N-(9Z,12Z-octadecadienoyl)-glutamine
|
NAGln 18:2
|
C23H40N2O4
|
408.298808
|
|
LMFA04020240
|
(4S,7S,11S)-d9-5-NeuroF[5S,8S]
|
(S)-4-hydroxy-4-((2S,4S,5S)-4-hydroxy-5-((S,1E,5Z,8Z,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)tetrahydrofuran-2-yl)butanoic acid
|
FA 22:5;O4
|
C22H34O6
|
394.235541
|
|
LMFA04020253
|
(4R,8S,11S)-d5-7-NeuroF[7S,10S]
|
(R,E)-4-hydroxy-6-((2S,3S,5S)-3-hydroxy-5-((S,3Z,6Z,9Z)-1-hydroxydodeca-3,6,9-trien-1-yl)tetrahydrofuran-2-yl)hex-5-enoic acid
|
FA 22:5;O4
|
C22H34O6
|
394.235541
|
|
LMFA04020261
|
(4S,8R,11S)-d5-7-NeuroF[7S,10S]
|
(S,E)-4-hydroxy-6-((2S,3R,5S)-3-hydroxy-5-((S,3Z,6Z,9Z)-1-hydroxydodeca-3,6,9-trien-1-yl)tetrahydrofuran-2-yl)hex-5-enoic acid
|
FA 22:5;O4
|
C22H34O6
|
394.235541
|
|
LMFA04020367
|
(11S,14S,17S)-d15-10-NeuroF[10R,13S]
|
(4Z,7Z)-9-((2R,3S,5S)-5-((1S,2E,4S,6Z)-1,4-dihydroxynona-2,6-dien-1-yl)-3-hydroxytetrahydrofuran-2-yl)nona-4,7-dienoic acid
|
FA 22:5;O4
|
C22H34O6
|
394.235541
|
|
LMFA01031038
|
Phlomic acid
|
Eicosa-7,8-dienoic acid
|
FA 20:2
|
C20H36O2
|
308.271531
|
|
LMFA02050001
|
(9Z,11E)-12-((3S,5R)-5-((R)-1-hydroxypropyl)-1,2-dioxolan-3-yl)dodeca-9,11-dienoic acid
|
(9Z,11E)-12-((3S,5R)-5-((R)-1-hydroxypropyl)-1,2-dioxolan-3-yl)dodeca-9,11-dienoic acid
|
FA 18:3;O3
|
C18H30O5
|
326.209326
|
|
LMFA02050001
|
(9Z,11E)-12-((3S,5R)-5-((R)-1-hydroxypropyl)-1,2-dioxolan-3-yl)dodeca-9,11-dienoic acid
|
(9Z,11E)-12-((3S,5R)-5-((R)-1-hydroxypropyl)-1,2-dioxolan-3-yl)dodeca-9,11-dienoic acid
|
FA 18:3;O3
|
C18H30O5
|
326.209326
|
|
LMFA02050001
|
(9Z,11E)-12-((3S,5R)-5-((R)-1-hydroxypropyl)-1,2-dioxolan-3-yl)dodeca-9,11-dienoic acid
|
(9Z,11E)-12-((3S,5R)-5-((R)-1-hydroxypropyl)-1,2-dioxolan-3-yl)dodeca-9,11-dienoic acid
|
FA 18:3;O3
|
C18H30O5
|
326.209326
|
|
LMFA03140005
|
19-hydroxy-Resolvin E1
|
5S,12R,18S,19-tetrahydroxy-6Z,8E,10E,14Z,16E-eicosapentaenoic acid
|
FA 20:5;O4
|
C20H30O6
|
366.204241
|
|
LMFA03140005
|
19-hydroxy-Resolvin E1
|
5S,12R,18S,19-tetrahydroxy-6Z,8E,10E,14Z,16E-eicosapentaenoic acid
|
FA 20:5;O4
|
C20H30O6
|
366.204241
|
|
LMFA03140005
|
19-hydroxy-Resolvin E1
|
5S,12R,18S,19-tetrahydroxy-6Z,8E,10E,14Z,16E-eicosapentaenoic acid
|
FA 20:5;O4
|
C20H30O6
|
366.204241
|
|
LMFA02000309
|
9-hydroxy-11Z-Octadecenoic acid
|
9-hydroxy-11Z-Octadecenoic acid
|
FA 18:1;O
|
C18H34O3
|
298.250796
|
|
LMFA02000309
|
9-hydroxy-11Z-Octadecenoic acid
|
9-hydroxy-11Z-Octadecenoic acid
|
FA 18:1;O
|
C18H34O3
|
298.250796
|
|
LMFA02000309
|
9-hydroxy-11Z-Octadecenoic acid
|
9-hydroxy-11Z-Octadecenoic acid
|
FA 18:1;O
|
C18H34O3
|
298.250796
|
|
LMFA02000313
|
9R,12R,13S-Trihydroxy-10E,15Z-octadecadienoic acid
|
9R,12R,13S-Trihydroxy-10E,15Z-octadecadienoic acid
|
FA 18:2;O3
|
C18H32O5
|
328.224976
|
|
LMFA02000313
|
9R,12R,13S-Trihydroxy-10E,15Z-octadecadienoic acid
|
9R,12R,13S-Trihydroxy-10E,15Z-octadecadienoic acid
|
FA 18:2;O3
|
C18H32O5
|
328.224976
|
|
LMFA02000313
|
9R,12R,13S-Trihydroxy-10E,15Z-octadecadienoic acid
|
9R,12R,13S-Trihydroxy-10E,15Z-octadecadienoic acid
|
FA 18:2;O3
|
C18H32O5
|
328.224976
|
|
LMFA07030003
|
Type IV cyanolipid 18:0 ester
|
(1-cyano-2-methylprop-2-en-1-yl) octadecanoate
|
|
C23H41NO2
|
363.313729
|
|
LMFA07030003
|
Type IV cyanolipid 18:0 ester
|
(1-cyano-2-methylprop-2-en-1-yl) octadecanoate
|
|
C23H41NO2
|
363.313729
|
|
LMFA07030003
|
Type IV cyanolipid 18:0 ester
|
(1-cyano-2-methylprop-2-en-1-yl) octadecanoate
|
|
C23H41NO2
|
363.313729
|
|
LMFA01140055
|
2-Cyclopentene-1S-tridecanoic acid
|
2-Cyclopentene-1S-tridecanoic acid
|
FA 18:2
|
C18H32O2
|
280.240231
|
|
LMFA01140055
|
2-Cyclopentene-1S-tridecanoic acid
|
2-Cyclopentene-1S-tridecanoic acid
|
FA 18:2
|
C18H32O2
|
280.240231
|
|
LMFA04020026
|
(13R,17S,20R)-d14-16-NeuroF[16S,19R]
|
(R,4Z,7Z,10Z,14E)-13-hydroxy-15-((2S,3S,5R)-3-hydroxy-5-((R)-1-hydroxypropyl)tetrahydrofuran-2-yl)pentadeca-4,7,10,14-tetraenoic acid
|
FA 22:5;O4
|
C22H34O6
|
394.235541
|
|
LMFA04020029
|
(13R,17S,20S)-d14-16-NeuroF[16S,19S]
|
(R,4Z,7Z,10Z,14E)-13-hydroxy-15-((2S,3S,5S)-3-hydroxy-5-((S)-1-hydroxypropyl)tetrahydrofuran-2-yl)pentadeca-4,7,10,14-tetraenoic acid
|
FA 22:5;O4
|
C22H34O6
|
394.235541
|
|
LMFA04020188
|
(7R,11S,14R)-d8-10-NeuroF[10R,13R]
|
(R,4Z,8E)-7-hydroxy-9-((2R,3S,5R)-3-hydroxy-5-((R,3Z,6Z)-1-hydroxynona-3,6-dien-1-yl)tetrahydrofuran-2-yl)nona-4,8-dienoic acid
|
FA 22:5;O4
|
C22H34O6
|
394.235541
|
|
LMFA04020086
|
(10R,13R,17S)-d15-11-NeuroF[11R,14S]
|
(R,4Z,7Z)-10-hydroxy-10-((2R,4R,5S)-4-hydroxy-5-((S,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)tetrahydrofuran-2-yl)deca-4,7-dienoic acid
|
FA 22:5;O4
|
C22H34O6
|
394.235541
|
|
LMFA04020103
|
(10S,13R,17S)-d15-11-NeuroF[11S,14R]
|
(S,4Z,7Z)-10-hydroxy-10-((2S,4R,5R)-4-hydroxy-5-((S,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)tetrahydrofuran-2-yl)deca-4,7-dienoic acid
|
FA 22:5;O4
|
C22H34O6
|
394.235541
|
|
LMFA04020186
|
(7R,11S,14R)-d8-10-NeuroF[10S,13R]
|
(R,4Z,8E)-7-hydroxy-9-((2S,3S,5R)-3-hydroxy-5-((R,3Z,6Z)-1-hydroxynona-3,6-dien-1-yl)tetrahydrofuran-2-yl)nona-4,8-dienoic acid
|
FA 22:5;O4
|
C22H34O6
|
394.235541
|
|
LMFA02030037
|
16-D1c-PhytoP
|
8-((1R,2S,5S)-5-hydroxy-2-((S,E)-3-hydroxypent-1-en-1-yl)-3-oxocyclopentyl)octanoic acid
|
FA 18:3;O3
|
C18H30O5
|
326.209326
|